# Genetic evaluation of five patients with ROHHAD-NET using whole genome sequencing and optical genome mapping

**Authors:** N. van Engelen, H. M. van Santen, F. van Dijk, M. M. Kleisman, J. H.M. Merks, A. Y.N. Schouten-van Meeteren, E. J. Kamping, K. Neveling, A. Hoischen, M. C.J. Jongmans, R. P. Kuiper

PMC · DOI: 10.1186/s13023-025-03938-3 · Orphanet Journal of Rare Diseases · 2025-08-07

## TL;DR

This study investigates the genetic basis of ROHHAD-NET, a rare condition, using genome sequencing and mapping in five patients but finds no shared genetic cause.

## Contribution

The study provides genome-wide evidence against a monogenetic cause for ROHHAD-NET and supports an autoimmune hypothesis.

## Key findings

- No candidate genetic variants were found in two or more patients.
- Genome-wide analysis did not reveal a monogenetic cause for ROHHAD-NET.
- Findings support an autoimmune origin for ROHHAD symptoms.

## Abstract

Rapid-onset obesity, hypothalamic dysfunction, hypoventilation, autonomic dysregulation (ROHHAD) and neuroendocrine tumor (NET) is a very rare condition with an unknown etiology. While various potential causes have been hypothesized, including genetic and paraneoplastic autoimmune mechanisms, no definitive cause has been identified to date. This study aimed to explore whether patients with ROHHAD-NET share an underlying heritable genetic etiology.

We identified five female patients clinically suspected of having ROHHAD(-NET); among them in two patients a NET was found: a ganglioneuroma and a low grade cerebellar ganglion cell tumor with BRAF mutation. To identify potential pathogenic germline genomic variants, whole genome sequencing (WGS) was performed on germline DNA from all five patients, including four patient-parent trios. Furthermore, optical genome mapping (OGM) was performed for two patients to detect germline structural variants (SVs). Rare single nucleotide variants (SNVs) and small insertions/deletions (InDels) were identified through WGS and rare SVs affecting (non)-coding or regulatory regions were analyzed using both WGS and OGM. We explored a de novo, inherited autosomal dominant and autosomal recessive inheritance scenario. However, no candidate variants in a recurrently affected gene locus or genomic region were identified in two or more patients.

Our comprehensive genome-wide data analysis did not reveal evidence of a monogenetic cause for ROHHAD-NET. Whereas these findings do not exclude a genetic etiology for ROHHAD-NET, they strengthen the hypothesis of an autoimmune origin for symptoms of ROHHAD.

The online version contains supplementary material available at 10.1186/s13023-025-03938-3.

## Linked entities

- **Genes:** BRAF (B-Raf proto-oncogene, serine/threonine kinase) [NCBI Gene 673]
- **Diseases:** ROHHAD-NET (MONDO:0017408), ganglioneuroma (MONDO:0005033)

## Full-text entities

- **Genes:** BRAF (B-Raf proto-oncogene, serine/threonine kinase) [NCBI Gene 673] {aka B-RAF1, B-raf, BRAF-1, BRAF1, NS7, RAFB1}
- **Diseases:** hypothalamic dysfunction (MESH:D007027), ganglioneuroma (MESH:D005729), obesity (MESH:D009765), NET (MESH:D018358), ROHHAD (MESH:D010845), cerebellar ganglion cell tumor (MESH:D002528), autonomic dysregulation (MESH:D021081), hypoventilation (MESH:D007040)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12333276/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12333276/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC12333276/full.md

---
Source: https://tomesphere.com/paper/PMC12333276